secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2023-07-05T23:59:59+00:00
Accession:  0001493152-23-023458
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq confirms Bone Biologics compliance with minimum bid price; one-year panel monitor imposed
--------------------------------------------------------------------------------

- Received letter from Nasdaq Hearings Advisor on June 28, 2023 confirming compliance with Listing Rule 5550(a)(2) for minimum bid price.
- Company subject to Panel Monitor through June 27, 2024; any future non-compliance triggers immediate delisting process with no cure period.
- During monitoring, failure to meet any continued listing requirement forfeits standard compliance plan and cure periods, risking delisting.
- Company's common stock (BBLG) and warrants (BBLGW) trade on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223023458/0001493152-23-023458-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223023458/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-023458

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer